Amnestic multi-domain MCI with positive AD biomarkers and APOE ε4 homozygosity carries a very high short-term risk of conversion to AD dementia, whereas non-amnestic single-domain MCI is more likely to remain stable or to evolve toward non-Alzheimer dementias [10,11,12,15]. The gene discussed is APOE; the disease is Alzheimer disease.